Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,195 | N/A | 1,198 | 679 | 1,236 |
| Marketable Securities | N/A | N/A | 118 | 162 | 266 |
| Receivables | N/A | N/A | 2,081 | 1,711 | 1,912 |
| Other current assets | 0 | 0 | 800 | 874 | 291 |
| TOTAL | $3,565 | $N/A | $4,677 | $3,861 | $3,999 |
| Non-Current Assets | |||||
| PPE Net | 1,394 | N/A | 634 | 568 | 602 |
| Intangibles | 0 | 0 | 707 | 899 | 1,140 |
| Other Non-Current Assets | 422 | 0 | 7,214 | 7,178 | 7,132 |
| TOTAL | $1,816 | $N/A | $8,555 | $8,645 | $8,874 |
| Total Assets | $5,381 | $N/A | $13,232 | $12,506 | $12,873 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 56 | 317 | 247 |
| Accounts payable and accrued liabilities | 342 | 0 | 245 | 301 | 360 |
| Accrued Expenses | 423 | N/A | 909 | 741 | 667 |
| Other current liabilities | 173 | N/A | 559 | 679 | 1,402 |
| TOTAL | $1,060 | $N/A | $7,277 | $7,306 | $7,342 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 0 | 56 | 122 |
| Deferred Revenues | N/A | N/A | 4,537 | 4,276 | 4,251 |
| Other Non-Current Liabilities | 764 | 0 | 5,566 | 5,638 | 4,967 |
| TOTAL | $774 | $N/A | $5,566 | $5,693 | $5,089 |
| Total Liabilities | $1,834 | $N/A | $12,843 | $12,999 | $12,431 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 10,752 | 10,617 | N/A |
| Common Shares | 0 | N/A | 1,075 | 1,070 | 1,019 |
| Retained earnings | -38,034 | N/A | -23,346 | -24,091 | -22,872 |
| Other shareholders' equity | 40,095 | 0 | -370 | -378 | -367 |
| TOTAL | $3,547 | $N/A | $389 | $-493 | $442 |
| Total Liabilities And Equity | $5,381 | $0 | $13,232 | $12,506 | $12,873 |